Heparin Sodium (Pfizer)

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Nopērc to tagad

Lejuplādēt Lietošanas instrukcija (PIL)
28-09-2012
Lejuplādēt Produkta apraksts (SPC)
27-06-2019

Aktīvā sastāvdaļa:

Heparin sodium 1000 IU/mL;  

Pieejams no:

Pfizer New Zealand Limited

SNN (starptautisko nepatentēto nosaukumu):

Heparin sodium 1000 IU/mL

Deva:

5000 IU/5mL

Zāļu forma:

Solution for injection

Kompozīcija:

Active: Heparin sodium 1000 IU/mL   Excipient: Hydrochloric acid Sodium hydroxide Water for injection

Vienības iepakojumā:

Ampoule, plastic, 5 mL lLDPE ampoules, 10s, 50 mL

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Pharmacia Hepar LLC

Produktu pārskats:

Package - Contents - Shelf Life: Ampoule, plastic, 5 mL lLDPE ampoules - 10 dose units - 24 months from date of manufacture stored at or below 25°C - Ampoule, plastic, 5 mL lLDPE ampoules - 50 dose units - 24 months from date of manufacture stored at or below 25°C

Autorizācija datums:

2009-04-21

Lietošanas instrukcija

                                HEPARIN INJECTION 
1 
HEPARIN INJECTION 
_ _
CONSUMER MEDICINE INFORMATION 
  
WHAT IS IN THIS LEAFLET 
This leaflet answers some common 
questions about Heparin Injection.  It 
does not contain all the available 
information.  It does not take the 
place of talking to your doctor or 
pharmacist. 
All medicines have benefits and 
risks.  Your doctor has weighed the 
risks of you using Heparin Injection 
against the benefits this medicine is 
expected to have for you. 
This medicine is likely to be used 
while you are at the clinic or in 
hospital.  If possible, please read this 
leaflet carefully before this medicine 
is given to you.  In some cases this 
leaflet may be given to you after the 
medicine has been used. 
IF YOU HAVE ANY CONCERNS ABOUT 
USING THIS MEDICINE, ASK YOUR 
DOCTOR OR PHARMACIST. 
KEEP THIS LEAFLET. 
You may need to read it again. 
WHAT HEPARIN 
INJECTION IS USED FOR 
Heparin Injection belongs to a group 
of medicines known as 
anticoagulants.  Anticoagulants work 
by decreasing the clotting ability of 
your blood and help stop clots 
forming in the blood vessels.  
Anticoagulants are sometimes called 
"blood thinners", although they do 
not actually thin the blood.  Heparin 
will not dissolve blood clots that 
have already formed, but it may 
prevent any clots that have already 
formed from becoming larger and 
causing serious problems. 
Heparin Injection is used for 
prevention and treatment of diseases 
caused by blood clots such as in 
certain blood vessel, heart and lung 
conditions.  It is also used to prevent 
blood clots from forming during 
surgery, dialysis or blood 
transfusions. 
Heparin Injection may be used for 
the treatment of other conditions that 
are not mentioned above.  Your 
doctor will be able to tell y
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                Version: pfdhepai11220
Supersedes: pfdhepai10219
Page 1 of 14
NEW ZEALAND DATA SHEET
1.
PRODUCT NAME
_ _
Heparin Sodium (Pfizer) 5000 IU/5mL, 25000 IU/5mL Solution for
Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ampoule contains Heparin sodium 1000 IU/mL or 5000 IU/mL, in 5mL
ampoules
Heparin sodium is a white or almost white powder, moderately
hygroscopic, freely soluble in
water.
Heparin sodium is a preparation containing the sodium salt of a
sulphated glucosaminoglycan
present in mammalian tissues. It is prepared from the lungs or from
the intestinal mucosae of
pigs.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection
Heparin Injection is a clear, colourless to straw coloured, sterile,
preservative-free solution
containing Heparin Sodium BP (porcine mucous) in Water for Injections
BP.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
•
prophylaxis
and
treatment
of
thromboembolic
disorders
such
as
thrombophlebitis,
pulmonary embolism, coronary or venous thrombosis and occlusive
vascular disease.
•
as a low-dose regimen for the prevention of thromboembolic
complications arising as a
result of cardiac and arterial surgery.
•
as an anticoagulant during blood transfusions, extracorporeal
circulation, dialysis and
other perfusion techniques and in blood samples for laboratory
purposes.
4.2 DOSE AND METHOD OF ADMINISTRATION
DOSE
Heparin Injection contains no antimicrobial agent and is therefore
intended for single use
only.
Heparin may be given by intermittent intravenous injection,
intravenous infusion or deep
subcutaneous injection. It should not be given intramuscularly due to
the risk of haematoma
Version: pfdhepai11220
Supersedes: pfdhepai10219
Page 2 of 14
formation at the injection site. There is a wide variation between
individuals in the dose
required to control thromboembolism and heparin dose is usually
determined empirically by
adjustment according to the results of laboratory tests.
THE DOSAGE OF HEPARIN SODIUM SHOULD BE ADJUSTED ACCORDING
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu